The 2024 Race Against Kids’ Cancer Frequently Asked Questions
How Do I Know If I Am Actually Registered?
If you registered for the 2024 Race Against Kids Cancer event, you should have received an email confirmation. This email should provide you with your account login and password. If you cannot find this confirmation, simply go to the website and click Log In and forgot my password.
If you should have any questions about registration or the event, please feel free to call 303-758-2130 or email firstname.lastname@example.org
Saturday – Sunday August 3-4, 2024
High Plains Raceway, Deer Trail CO Click here to view a map
You don’t have to be a race car driver to see what all the racing fun is about! The Race Against Kids’ Cancer features lunch rides on the racetrack in race, sports, and exotic cars where spectators can make a donation to MAF and get a ride with a qualified car & driver to see what it’s like to be out there on the track at race speed.
Racing begins approximately 8:00am. Lunch Rides begin at 11:30am.
The races are open to the public and are FREE to attend.
Any race enthusiasts who raises at least $50 towards the event will be provided a 2024 event t-shirt. T-shirts will be available at the track and available for purchase.
Saturday Evening Driver Dinner
Race attendees are encouraged to purchase their Saturday evening dinner ticket through the RMVR website.
Why support the Race Against Kids Cancer event?
The Morgan Adams Foundation funds kids’ cancer research. We raise awareness of, and educate our communities about, the need for pediatric and young adult specific cancer treatments.
Working with leading researchers and physicians, we fund new and innovative ideas that will improve cancer treatment effectiveness, overall outcomes, survival rates and quality of life while minimizing the devastating side effects current treatments have on our children.
Our particular interest is to provide seed and bridge grants for viable investigations not yet ripe enough for total funding by larger organizations. Additionally, we are able to partially fund translational studies, experimental therapeutics studies, and/or Phase I and II clinical trials on a case-by-case basis.
We increasingly seek projects that are highly collaborative and/or multi-institutional in nature. Our hope is that we can facilitate, through strategic funding, more rapid clinical trial development to get the best possible treatment options into circulation as expediently as possible.
Through careful consideration and placement of our funding, we encourage and support research intended to improve treatment effectiveness, treatment outcomes, and the quality of life for children battling cancer.
Help give kids with cancer MORE THAN HOPE!